久久窝窝国产精品午夜看片,99热成人精品,国产AV国片精品A片,欧美一级aa系列婷婷99,成一级女人大片在线视频,久久成人免费视频天天看,国产一线二线三线自拍,久久久久久久久久中文字幕,色婷婷综合久久久久中文一区二区,91亚洲精品,亚洲色欲久久久综合网,激情偷乱人成视频在线观看,亚洲 日韩成人,国产中文字幕乱人伦在线,久久私人影院香蕉,无码熟妇人妻AV在线影院,亚洲永久精品免费ww52com

What is the registration process for in vitro diagnostics in the United States?
Category：企業(yè)動(dòng)態(tài) Date：2025-01-10 17:29:19 Author: Source:
The registration process for in vitro diagnostics (IVDs) in the United States involves several steps regulated by the U.S. Food and Drug Administration (FDA). Below is an overview of the process:

The registration process for in vitro diagnostics (IVDs) in the United States involves several steps regulated by the U.S. Food and Drug Administration (FDA). Below is an overview of the process:

  1. Determine the Classification: IVDs are classified into three categories (Class I, Class II, or Class III) based on risk. The classification determines the regulatory requirements, including the level of oversight needed.

  2. 底部圖3(1).png

  3. Pre-market Notification (510(k)) or Pre-market Approval (PMA):

    • 510(k) Submission: Most Class II devices (and some Class I devices) require a 510(k) pre-market notification. This involves submitting evidence that the device is substantially equivalent to an already legally marketed device.
    • PMA: Class III devices (high-risk IVDs) require pre-market approval. This involves submitting clinical trial data and other information to prove the device’s safety and effectiveness.

  4. Establish a Quality Management System (QMS): Manufacturers must comply with the FDA’s Quality System Regulation (QSR) (21 CFR 820), ensuring that the device is manufactured in accordance with strict quality control standards.

  5. Labeling Requirements: IVDs must comply with the FDA’s labeling regulations, which include providing clear and accurate instructions for use, as well as warnings and other important information.

  6. Registration and Listing:

    • Manufacturers must register their establishment with the FDA and list their IVD product(s) with the FDA.
    • This process involves submitting the device’s details, including its intended use and classification.

  7. Post-Market Surveillance: After the device is marketed, manufacturers must monitor and report any adverse events or product defects to the FDA. In some cases, post-market clinical studies or additional regulatory approvals may be required.

Each step may vary depending on the risk classification of the device, and additional requirements may apply for certain types of IVDs (e.g., laboratory-developed tests or home-use tests). It's important to consult with the FDA or a regulatory expert to ensure compliance with all applicable regulations.

Contact Us：

Whatsapp or Wechat：+86 15816864648；email address：hito.lin@grzan.cn